Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin (EXPLORE-Xa)

This study has been completed.
Information provided by:
Portola Pharmaceuticals Identifier:
First received: August 26, 2008
Last updated: June 7, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)